ARTICLE | Company News
AmDerma Pharmaceuticals LLC, Oculus deal
February 21, 2011 8:00 AM UTC
Oculus granted AmDerma an option to license Oculus' Microcyn technology for $500,000 for a yet to be determined formulation to treat acne. If AmDerma exercises its option, Oculus will receive an undi...